{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:05:08Z","timestamp":1781629508587,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["1030-00474B"],"award-info":[{"award-number":["1030-00474B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008361","name":"Scleroseforeningen","doi-asserted-by":"publisher","award":["R588-A40233"],"award-info":[{"award-number":["R588-A40233"]}],"id":[{"id":"10.13039\/100008361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R155-2013-14113"],"award-info":[{"award-number":["R155-2013-14113"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007371","name":"Svend Andersen Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007371","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The blood-brain barrier (BBB) formed by brain endothelial cells (BECs) limits the passage of biopharmaceuticals from the circulation to the brain parenchyma. Genetically modified BECs enable protein secretion to the brain and provide a novel strategy to obtain brain uptake of otherwise BBB-impermeable proteins. However, secretion from BECs may be bidirectional, thereby leading to off-target secretion into the blood. This study investigates a vector strategy using the brain-specific AAV-BR1 viral vector to achieve specific transduction of BECs and to subsequently direct the recombinant proteins towards an abluminal secretion pathway, thereby increasing the release of recombinant proteins into the brain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Different AAV-BR1 constructs, under the control of an endothelial-specific promoter (C-\n                      <jats:italic>Ocln<\/jats:italic>\n                      ), were designed to include a fragment of the platelet-derived growth factor subunit B protein (PDGF-B) fused to the N-terminus of mCherry to promote abluminal secretion. Similar constructs using the more ubiquitous expressed CAG promoter were used for comparisons. The correct processing of the vector constructs was confirmed in vitro, including post-translational removal of the PDGF-B fragment by furin cleavage. AAV-BR1 vector constructs containing the C-\n                      <jats:italic>Ocln<\/jats:italic>\n                      promoter and the PDGF-B fragment were systemically administered in C57Bl\/6J mice to evaluate abluminal secretion of mCherry to the brain parenchyma specifically by BECs. An in vitro BBB co-culture model based on primary mouse BECs and mixed glial cells was likewise used to evaluate if the PDGF-B fragment enhanced abluminal secretion of mCherry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The C-\n                      <jats:italic>Ocln<\/jats:italic>\n                      promoter exhibited low specificity to BECs, off-target transduction of neurons, and low transduction efficiency, which complicated the in vivo quantification of mCherry secretion into the brain parenchyma. Modelling the BBB in vitro showed higher mCherry secretion across the abluminal membrane when the PDGF-B fragment was included in the vector construct, especially in combination with the CAG promoter.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Investigating abluminal secretion of mCherry was complicated in vivo by high off-target transduction of neurons, despite using the endothelial-specific promoter (C-\n                      <jats:italic>Ocln<\/jats:italic>\n                      ). In vitro results, however, suggest that incorporating a PDGF-B fragment into the vector design targets the recombinant protein for abluminal secretion by BECs and facilitates increased protein delivery to the brain.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-025-00738-6","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T03:18:18Z","timestamp":1765509498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel vector design targeting the blood-brain barrier with the brain-specific AAV-BR1 vector enables abluminal protein secretion from brain endothelial cells in vitro"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5209-9562","authenticated-orcid":false,"given":"Bartosz","family":"Laczek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-7039","authenticated-orcid":false,"given":"Maj Schneider","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5435-7182","authenticated-orcid":false,"given":"Jakob","family":"K\u00f6rbelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2086-4693","authenticated-orcid":false,"given":"Annette","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-0207","authenticated-orcid":false,"given":"Torben","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"738_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2:3\u201314.","journal-title":"NeuroRx"},{"key":"738_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-3-319-91442-8_4","volume":"211","author":"DF Heigener","year":"2018","unstructured":"Heigener DF, Reck M, Crizotinib. Recent Results Cancer Res. 2018;211:57\u201365.","journal-title":"Recent Results Cancer Res"},{"key":"738_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2021.01.015","volume":"171","author":"A D\u2019Souza","year":"2021","unstructured":"D\u2019Souza A, Dave KM, Stetler RA, Manickam S. Targeting the blood-brain barrier for the delivery of stroke therapies. Adv Drug Deliv Rev. 2021;171:332\u201351.","journal-title":"Adv Drug Deliv Rev"},{"key":"738_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/jnc.14982","volume":"156","author":"E Hede","year":"2021","unstructured":"Hede E, Christiansen CB, Heegaard CW, Moos T, Burkhart A. Gene therapy to the blood\u2013brain barrier with resulting protein secretion as a strategy for treatment of Niemann picks type C2 disease. J Neurochem. 2021;156:290\u2013308.","journal-title":"J Neurochem"},{"key":"738_CR5","doi-asserted-by":"crossref","unstructured":"Rasmussen CLM, Hede E, Routhe LJ, K\u00f6rbelin J, Helgudottir SS, Thomsen LB, et al. A novel strategy for delivering niemann-pick type C2 proteins across the blood\u2013brain barrier using the brain endothelial-specific AAV-BR1 virus. J Neurochem [Internet]. 2023 [cited 2024 Apr 5];164:6\u201328. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35554935\/","DOI":"10.1111\/jnc.15621"},{"key":"738_CR6","doi-asserted-by":"crossref","unstructured":"Rasmussen CLM, Frederiksen SF, Heegaard CW, Thomsen MS, Hede E, Laczek B, et al. Endothelial and neuronal engagement by AAV-BR1 gene therapy alleviates neurological symptoms and lipid deposition in a mouse model of Niemann-Pick type C2. Fluids Barriers CNS [Internet]. 2025 [cited 2025 Feb 6];22:13. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39891227","DOI":"10.1186\/s12987-025-00621-4"},{"key":"738_CR7","doi-asserted-by":"crossref","unstructured":"K\u00f6rbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J, et al. A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med [Internet]. 2016 [cited 2017 Mar 16];8:609\u201325. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27137490","DOI":"10.15252\/emmm.201506078"},{"key":"738_CR8","doi-asserted-by":"crossref","unstructured":"Burkhart A, Andresen TL, Aigner A, Thomsen LB, Moos T. Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain. Cell Mol Life Sci [Internet]. 2017 [cited 2017 Mar 16];74. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28293718","DOI":"10.1007\/s00018-017-2501-5"},{"key":"738_CR9","doi-asserted-by":"crossref","unstructured":"Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, et al. Crystal structure of the GLP-1 receptor bound to a peptide agonist. Nature [Internet]. 2017 [cited 2025 Jun 4];546:254\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28562585\/","DOI":"10.1038\/nature22800"},{"key":"738_CR10","doi-asserted-by":"crossref","unstructured":"Wei H, Sundararaman A, Dickson E, Rennie-Campbell L, Cross E, Heesom KJ, et al. Characterization of the polarized endothelial secretome. FASEB J [Internet]. 2019 [cited 2025 Jun 4];33:12277\u201387. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31431053\/","DOI":"10.1096\/fj.201900262R"},{"key":"738_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000512618","volume":"58","author":"AG Wolpe","year":"2021","unstructured":"Wolpe AG, Ruddiman CA, Hall PJ, Isakson BE. Polarized proteins in endothelium and their contribution to function. J Vasc Res. 2021;58:65\u201391.","journal-title":"J Vasc Res"},{"key":"738_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/0271678X15608644","volume":"36","author":"T Worzfeld","year":"2016","unstructured":"Worzfeld T, Schwaninger M. Apicobasal Polarity of brain endothelial cells. J Cereb Blood Flow Metab. 2016;36:340\u201362.","journal-title":"J Cereb Blood Flow Metab"},{"key":"738_CR13","doi-asserted-by":"crossref","unstructured":"Gra\u00dfhoff H, M\u00fcller-Fielitz H, Dogbevia GK, K\u00f6rbelin J, Bannach J, Vahldieck CMG, et al. Short regulatory DNA sequences to target brain endothelial cells for gene therapy. J Cereb Blood Flow Metab [Internet]. 2022 [cited 2025 Jun 4];42:104\u201320. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34427142\/","DOI":"10.1177\/0271678X211039617"},{"key":"738_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00441-003-0745-x","volume":"314","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 2003;314:15\u201323.","journal-title":"Cell Tissue Res"},{"key":"738_CR15","doi-asserted-by":"crossref","unstructured":"Zerwes HG, Risau W. Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J Cell Biol [Internet]. 1987 [cited 2025 Jun 4];105:2037\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/3680370\/","DOI":"10.1083\/jcb.105.5.2037"},{"key":"738_CR16","doi-asserted-by":"crossref","unstructured":"Thomsen MS, Humle N, Hede E, Moos T, Burkhart A, Thomsen LB. The blood-brain barrier studied in vitro across species. PLoS One [Internet]. 2021 [cited 2021 Jun 16];16. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33711041\/","DOI":"10.1371\/journal.pone.0236770"},{"key":"738_CR17","doi-asserted-by":"crossref","unstructured":"Thomsen MS, Birkelund S, Burkhart A, Stensballe A, Moos T. Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood-brain barrier. J Neurochem [Internet]. 2017 [cited 2017 Jul 11];140:741\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27456748","DOI":"10.1111\/jnc.13747"},{"key":"738_CR18","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1113\/JP280389","volume":"598","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Physiol. 2020;598:3793\u2013801.","journal-title":"J Physiol"},{"key":"738_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"738_CR20","doi-asserted-by":"crossref","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res [Internet]. 2001;29:e45. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11328886","DOI":"10.1093\/nar\/29.9.e45"},{"key":"738_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1089\/104303403322168019","volume":"14","author":"C Jiang","year":"2003","unstructured":"Jiang C, Koyabu N, Yonemitsu Y, Shimazoe T, Watanabe S, Naito M, et al. In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells. Hum Gene Ther. 2003;14:1181\u201391.","journal-title":"Hum Gene Ther"},{"key":"738_CR22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/bit.24776","volume":"110","author":"L Kober","year":"2013","unstructured":"Kober L, Zehe C, Bode J. Optimized signal peptides for the development of high expressing CHO cell lines. Biotechnol Bioeng. 2013;110:1164\u201373.","journal-title":"Biotechnol Bioeng"},{"key":"738_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejcb.2018.06.003","volume":"97","author":"H Owji","year":"2018","unstructured":"Owji H, Nezafat N, Negahdaripour M, Hajiebrahimi A, Ghasemi Y. A comprehensive review of signal peptides: Structure, roles, and applications. Eur J Cell Biol. 2018;97:422\u201341.","journal-title":"Eur J Cell Biol"},{"key":"738_CR24","doi-asserted-by":"crossref","unstructured":"Winkler EA, Bell RD, Zlokovic BV. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegener [Internet]. 2010 [cited 2025 Jul 9];5. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20738866\/","DOI":"10.1186\/1750-1326-5-32"},{"key":"738_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165:535\u201350.","journal-title":"Cell"},{"key":"738_CR26","doi-asserted-by":"crossref","unstructured":"Petrova R, Patil AR, Trinh V, McElroy KE, Bhakta M, Tien J, et al. Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB. Sci Rep [Internet]. 2023 [cited 2025 Jun 4];13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37794029\/","DOI":"10.1038\/s41598-023-42431-4"},{"key":"738_CR27","doi-asserted-by":"crossref","unstructured":"Dislich B, Wohlrab F, Bachhuber T, M\u00fcller SA, Kuhn PH, Hogl S, et al. Label-free quantitative proteomics of mouse cerebrospinal fluid detects \u03b2-site APP cleaving enzyme (BACE1) protease substrates in vivo. Mol Cell Proteomics [Internet]. 2015 [cited 2025 Jun 4];14:2550\u201363. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26139848\/","DOI":"10.1074\/mcp.M114.041533"},{"key":"738_CR28","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/ejn.13933","volume":"47","author":"SV Morgan","year":"2018","unstructured":"Morgan SV, Garwood CJ, Jennings L, Simpson JE, Castelli LM, Heath PR, et al. Proteomic and cellular localisation studies suggest non-tight junction cytoplasmic and nuclear roles for occludin in astrocytes. Eur J Neurosci. 2018;47:1444\u201356.","journal-title":"Eur J Neurosci"},{"key":"738_CR29","doi-asserted-by":"crossref","unstructured":"Inoue F, Kircher M, Martin B, Cooper GM, Witten DM, McManus MT, et al. A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity. Genome Res [Internet]. 2017 [cited 2025 Jun 4];27:38\u201352. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27831498\/","DOI":"10.1101\/gr.212092.116"},{"key":"738_CR30","doi-asserted-by":"crossref","unstructured":"Huang Q, Chan KY, Tobey IG, Chan YA, Poterba T, Boutros CL, et al. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS One [Internet]. 2019 [cited 2025 Jun 4];14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31725765\/","DOI":"10.1101\/538421"},{"key":"738_CR31","doi-asserted-by":"publisher","first-page":"e39036","DOI":"10.1371\/journal.pone.0039036","volume":"7","author":"S Ohshima-Hosoyama","year":"2012","unstructured":"Ohshima-Hosoyama S, Simmons HA, Goecks N, Joers V, Swanson CR, Bondarenko V, et al. A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys. PLoS ONE. 2012;7:e39036.","journal-title":"PLoS ONE"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00738-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00738-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:26:45Z","timestamp":1781627205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-025-00738-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00738-6","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal studies were performed in accordance with the Danish Animal Experimentation Act (BEK no. 2028 of 14 December 2020) and the European Directive (2010\/63\/EU) and were carried out by licensed staff. The Danish Animal Experiments Inspectorate, under the Ministry of Food, Agriculture, and Fisheries, has approved all animal experiments (License No. 2018-15-0201-01467).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JK is listed as an inventor on a patent on AAV-BR1, held by Boehringer Ingelheim International. All other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}